Table_5_Decreased Functional Connectivities of Low-Degree Level Rich Club Organization and Caudate in Post-stroke Cognitive Impairment Based on Resting-State fMRI and Radiomics Fea... by Guofu Miao (11271528)

SIVcol Nef counteracts SERINC5 by promoting its proteasomal degradation but does not efficiently enhance HIV-1 replication in human CD4+ T cells and lymphoid tissue by Dorota Kmiec (5646374)

“…Here, we show that the Nef protein of the highly divergent SIVcol lineage infecting mantled guerezas (<i>Colobus guereza</i>) is a potent antagonist of SERINC5, although it lacks the CD4, CD3 and CD28 down-modulation activities exerted by other primate lentiviral Nefs. …”

Pharmacological Mechanism of the Non-hallucinogenic 5‑HT_2A Agonist Ariadne and Analogs by Michael J. Cunningham (14267038)

“…Compared to DOM, Ariadne shows lower signaling potency and efficacy in multiple signaling pathways examined (G_q, G₁₁, and β-arrestin2) coupled to 5-HT_2A receptors. We confirmed the shift in signaling for an α-propyl analog and provide a molecular docking rationale for the progressive decrease in signaling potency with the growing length of the α-substituent. …”

Pharmacological Mechanism of the Non-hallucinogenic 5‑HT_2A Agonist Ariadne and Analogs by Michael J. Cunningham (14267038)

“…Compared to DOM, Ariadne shows lower signaling potency and efficacy in multiple signaling pathways examined (G_q, G₁₁, and β-arrestin2) coupled to 5-HT_2A receptors. We confirmed the shift in signaling for an α-propyl analog and provide a molecular docking rationale for the progressive decrease in signaling potency with the growing length of the α-substituent. …”

PRISMA flow diagram. by Santiago Avila-Rios (3160959)

Subjects:

PDR meta-analysis for the LAC region, 2000–2015. by Santiago Avila-Rios (3160959)

Subjects:

Publications on HIV PDR in the Andean Region, 2000–2015. by Santiago Avila-Rios (3160959)

Subjects:

Publications on HIV PDR in Brazil, 2000–2015. by Santiago Avila-Rios (3160959)

Subjects:

Publications on HIV PDR in the Mesoamerican Region, 2000–2015. by Santiago Avila-Rios (3160959)

Subjects:

Publications on HIV PDR in the Southern Cone, 2000–2015. by Santiago Avila-Rios (3160959)

Subjects:

Publications on HIV PDR in the Caribbean, 2000–2015. by Santiago Avila-Rios (3160959)

Subjects:

Characteristics of participants in the surveys included in the present review per region. by Santiago Avila-Rios (3160959)

Subjects:

HIV subtype distribution in Brazil. by Santiago Avila-Rios (3160959)

Subjects:

HIV subtype distribution in the LAC region. by Santiago Avila-Rios (3160959)

Subjects:

Drug resistance mutation frequency comparison, 2000–2005 vs. 2006–2015, for Brazil. by Santiago Avila-Rios (3160959)

Subjects:

Drug resistance mutation frequency comparison, 2000–2005 vs. 2006–2015, for the Caribbean. by Santiago Avila-Rios (3160959)

Subjects:

Drug resistance mutation frequency comparison, 2000–2005 vs. 2006–2015, for the Southern Cone. by Santiago Avila-Rios (3160959)

Subjects:

Drug resistance mutation frequency comparison, 2000–2005 vs. 2006–2015, for the Andean region. by Santiago Avila-Rios (3160959)

Subjects:

Drug resistance mutation frequency comparison, 2000–2005 vs. 2006–2015, for the Mesoamerican region. by Santiago Avila-Rios (3160959)

Subjects:

Drug resistance mutation frequency comparison, 2000–2005 vs. 2006–2015, for the whole LAC region. by Santiago Avila-Rios (3160959)

Subjects: